Ubs Group Ag Silo Pharma, Inc. Call Options Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SILO
# of Institutions
13Shares Held
338KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny227KShares$195,2250.0% of portfolio
-
Geode Capital Management, LLC Boston, MA30.8KShares$26,4540.0% of portfolio
-
Virtu Financial LLC New York, NY25.6KShares$22,0280.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.3KShares$14,0470.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il14.4KShares$12,3600.0% of portfolio
About Silo Pharma, Inc.
- Ticker SILO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,137,910
- Market Cap $2.7M
- Description
- Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...